Stage III Non-Small Cell Lung Cancer
Both males and females
18 years and above
This study for patients with Stage III non-small cell lung cancer seeks to assess whether the addition of oral veliparib versus placebo to Paclitaxel/Carboplatin-based chemoradiotherapy with Paclitaxel/Carboplatin consolidation will improve progression-free survival.
Phone Number: (08) 9446 8726
Location: 55/85 Monash Avenue, Nedlands, Western Australia, Australia
Approved By: Hollywood Private Hospital Research Ethics Committee
Clinical Trial Registry Link: